Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

AeroMed Technologies’ Innovative COVID-19 and Airborne Infection Control Solutions at 7 Top Hospitals

AeroMed Technologies’ infectious disease solutions appear in a number of top hospitals and healthcare facilities throughout the United States and internationally thanks to their proven track record. From New York to California to India, these clients include:

  • Kings County Hospital – Brooklyn, NY
  • Coney Island Hospital – Brooklyn, NY
  • Bellevue Hospital – Manhattan, NY
  • National Institute of Tuberculosis and Respiratory Disease – New Delhi, India
  • NYC Health + Hospitals Corporation (HHC) – New York, NY
  • Hospital for Special Surgery (HSS) – New York, NY
  • Los Angeles County Department of Public Health – California

AeroMed Technologies solutions are comprised of either HEPA filtration-based air purifiers or upper-room germicidal ultraviolet (GUV) lights. According to Palmer, client solutions are customized based on the unique configuration of the hospital or healthcare facility and its specific needs.

“The goal of both systems is to reduce the risk of infection by diluting the concentration of viable microbes in the air, whether they’re viruses or bacteria,” Palmer explains. “GUV lights reduce the concentration of viable pathogens by inactivating microbes in the air – it doesn’t remove them but disinfects them so they can no longer cause infection. HEPA filtration relies on moving air through a series of filters to physically remove those same microbes from the air. We are often able to combine both HEPA filtration and GUV into the same product. This protects both the room occupant and the person who eventually will service the air purifier.”

Upper-room GUV lights are a crucial, cost-effective product in the fight against COVID-19 and have been provided to clients by AeroMed for the past 10 years for airborne infectious disease applications around the world.

AeroMed Technologies’ upper-room GUV lights are thoroughly tested and vetted by an independent laboratory for performance. This technology is recommended by the Centers for Disease Control and Prevention (CDC) for COVID-19 applications, stating that upper-room UVG lights “can be used to provide air cleaning within occupied spaces.”

“Our solutions not only provide healthcare professionals peace of mind about working in at-risk settings, but they also create a sense of safety for patients and visitors,” says Palmer. “Some local hospitals, for example, are showing their infection control equipment in advertising to show that they’re taking action to reduce the risk to their patients and employees.”

AeroMed Technologies brings over 30-years’ experience providing such infectious pathogen solutions to the healthcare industry – long before the COVID-19 outbreak began. Its representatives work with experts around the world to ensure their upper-room GUV light and HEPA filtration systems are properly deployed to reduce the risk of airborne infection. During installation, AeroMed Technologies conducts further testing to ensure that the GUV lights, once installed, are effective against pathogens and safe for room occupants.

“We have a proven track record of applying these technologies before most others currently serving the industry and take pride in our effective systems, which are applied based on the unique requirements of each facility,” says Palmer. “Hospitals and healthcare providers can trust AeroMed Technologies to perform a risk assessment, recommend the most viable solutions for their needs, and implement the technology correctly to reduce risk in their facility.”

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy